Tekla Capital Management LLC - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 10 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q2 2015$1,041,000
-73.2%
354,047
-74.6%
0.04%
-75.3%
Q1 2015$3,889,000
+22.6%
1,394,000
-0.7%
0.15%
+3.4%
Q4 2014$3,173,000
-24.9%
1,404,0000.0%0.15%
-24.7%
Q3 2014$4,226,000
-21.0%
1,404,0000.0%0.20%
-59.7%
Q2 2014$5,349,000
-13.4%
1,404,0000.0%0.49%
-20.6%
Q1 2014$6,178,000
+18.9%
1,404,0000.0%0.62%
+13.4%
Q4 2013$5,195,000
+52.7%
1,404,000
-19.1%
0.54%
+44.2%
Q3 2013$3,401,000
+21.0%
1,735,0000.0%0.38%
-1.0%
Q2 2013$2,811,0001,735,0000.38%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q2 2013
NameSharesValueWeighting ↓
FIRST FOUNDATION ADVISORS 50,000$90,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 16,120$29,0000.01%
Nine Chapters Capital Management LLC 12,900$23,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 1,027$2,0000.00%
GROUP ONE TRADING, L.P. 12,109$22,0000.00%
1832 Asset Management L.P. 10,012$18,0000.00%
TORONTO DOMINION BANK 34$00.00%
DEUTSCHE BANK AG\ 117,727$213,0000.00%
MORGAN STANLEY 59,700$109,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders